Glabellar Lines
📧 Sign up to get email alerts when something new happens for Glabellar Lines.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Evaluate AI-09 In Participants With Glabellar Lines [Phase 2]
Phase 2 clinical trial update for AI-09 in treating glabellar lines; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL) [Phase 1]
A Phase 1 study comparing intramuscular injections of AGN-151586 and OnabotulinumtoxinA for glabellar lines has completed and reported adver…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 non-inferiority trial comparing AbobotulinumtoxinA from Espad Pharmed with Dysport for correction of moderate to severe glabellar li…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines [Phase 3]
AbbVie completed a Phase 3 study evaluating AGN-151586 injections for treating glabellar lines.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin
This non-interventional study of Dysport for glabellar lines in Chinese-origin subjects has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines [Phase 3]
A Phase 3 study to assess adverse events of intramuscular AGN-151586 for glabellar lines has completed, evaluating safety in adult participa…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 clinical trial comparing HG102 to Botox in adults with moderate to severe glabellar lines to evaluate safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial [Phase 3]
Phase 3 trial update on CKDB-501A shows efficacy and safety in treating moderate-to-severe glabellar lines.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines [Phase 2]
Phase 2 dose-ranging trial of AGN-151586 for treatment of glabellar lines has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines [Phase 3]
A Phase 3 clinical trial evaluating MT10109L for treating lateral canthal lines, with or without concurrent glabellar line treatment, has co…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Phase 2 of HU-045 in Glabellar Lines [Phase 2]
Phase 2 trial of HU-045 in glabellar lines completed.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: MT10109L in the Treatment of Glabellar Lines [Phase 3]
Phase 3 trial for MT10109L in treating glabellar lines has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines [Phase 2]
Phase 2 clinical trial results for DaxibotulinumtoxinA (DAXI) for injection show efficacy and safety in treating upper facial lines (glabell…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines [Phase 3]
Phase 3 trial update for long-term treatment of glabellar lines and lateral canthal lines shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL) [Phase 3]
Phase 3 trial evaluating MT10109L for glabellar lines with or without concurrent treatment of lateral canthal lines has completed and result…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines [Phase 2]
A Phase II clinical trial evaluating the efficacy and safety of MBA-P01 in adults with moderate to severe glabellar lines has been completed…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Treatment of Moderate to Severe Glabellar Lines (BMI2006) [Phase 3]
Phase 3 clinical trial update for BMI2006 treating moderate to severe glabellar lines has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of daxibotulinumtoxinA for injection to treat moderate to severe glabellar lines h…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial assessing safety of single and repeat treatments of DaxibotulinumtoxinA for Injection for moderate to severe glabellar lines h…
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines [Phase 3]
Phase 3 trial update assessing safety and efficacy of NT 201 (IncobotulinumtoxinA) for glabellar frown lines is completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of abobotulinumtoxinA for treatment of glabellar lines has completed with poste…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Dysport in the Treatment of Glabellar Lines in Chinese Subjects [Phase 3]
Phase 3 trial update for Dysport in treating glabellar lines in Chinese subjects has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines [Phase 3]
Phase 3 trial evaluating efficacy and safety of BTX-A-HAC NG in treating glabellar lines has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001 [Phase 3]
Phase III trial evaluating the safety and efficacy of DWP-450 for treating glabellar lines has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines [Phase 4]
Phase 4 trial comparing Dysport reconstitution at 1.5 mL vs 2.5 mL for moderate to severe glabellar lines; completed with results posted.